DESCRIPTION
TECENTRIQ 1200mg (Atezolizumab) is a cancer immunotherapy designed to work with the body’s own immune system. TECENTRIQ is the first and only approved anti-PDL1 medicine for patients with specific types of advanced urothelial carcinoma and non-small cell lung cancer.
Manufacturer : Genentech, Inc.
SIDE EFFECTS
Most common side effects are Decreased appetite, Nausea, Urinary tract or other infection, Constipation, Fever, Diarrhea, Colitis (bowel inflammation), Swelling, Abdominal pain, Vomiting, Shortness of breath and/or cough and/or wheezing, Neck pain/back pain, Rash and/or itching, Hematuria (blood in the urine), Arthralgia (joint pain), Hyponatremia (low sodium level), Thyroid changes, Autoimmune reactions* and infusion reactions.
Reviews
There are no reviews yet.